Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $462.21 USD
Change Today +9.79 / 2.16%
Volume 641.7K
REGN On Other Exchanges
As of 3:30 PM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Terifay

Senior Vice President of Commercial, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2013


Mr. Robert J. Terifay has been a Senior Vice President of Commercial at Regeneron Pharmaceuticals, Inc. since February 26, 2007. Prior to Regeneron, Mr. Terifay served as the President and Chief Operating Officer at Arginox Pharmaceuticals, Inc from January 2006 to October 2006. He has more than 20 years of experience in the life science industry and has experience in commercial strategy and positioning new products for market-entry in the pharmaceutical industry. Prior ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-847-7000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


University of Notre Dame
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$814,500

Stock Options*

All Other Compensation$17,145
Exercised Options21,628
Exercised Options Value$5,290,120
Exercisable Options184,670
Exercisable Options Value$42,757,996
Unexercisable Options179,375
Unexercisable Options Value$22,142,794
Total Value of Options$70,190,909
Total Number of Options385,673

Total Compensation*

Total Annual Cash Compensation$831,645
Total Short Term Compensation$814,500
Other Long Term Compensation$17,145
Total Calculated Compensation$7,679,131
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $462.21 USD +9.79


Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
Robert W. Duggan Chairman and Chief Executive Officer
Pharmacyclics Inc.
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
Jean-Christophe Tellier Chief Executive Officer and Executive Director
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at